BioPharma Credit PLC (OTCMKTS:BOPCF) Short Interest Down 50.0% in June

BioPharma Credit PLC (OTCMKTS:BOPCFGet Free Report) was the target of a significant decline in short interest in the month of June. As of June 15th, there was short interest totalling 100 shares, a decline of 50.0% from the May 31st total of 200 shares. Based on an average trading volume of 10,000 shares, the days-to-cover ratio is presently 0.0 days.

BioPharma Credit Stock Performance

BOPCF stock remained flat at $0.87 on Friday. BioPharma Credit has a fifty-two week low of $0.54 and a fifty-two week high of $1.25. The firm has a 50 day moving average of $0.88 and a 200 day moving average of $0.90.

BioPharma Credit Company Profile

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

Further Reading

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.